CDRO
Codere Online Luxembourg, S.A.
There isn't enough reported data to score CDRO yet.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
CDRO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
CDRO's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CDRO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 72x | $7.22 | -15% |
| Fair | 79x | $7.94 | -7% |
| Current | 85x | $8.54 | — |
| Expensive | 89x | $8.89 | +4.1% |
Historical ranges are pointers, not guarantees.
CDRO's PE is 85x, but its earnings don't support one, so it isn't a reliable read right now.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over CDRO in the historical PE scenario, which offers more potential upside but is not a forecast.
CDRO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
CDRO has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CDRO Earnings Per Share
CDRO and NKE do not have enough comparable growth data to identify a winner.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CDRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $109.5M | +13% |
| Q2 2024 | $56.7M | +37% |
| Q1 2024 | $56.7M | +37% |
| Q4 2023 | $96.7M | -25% |
| Q4 2022 | $128.6M | +44% |
| Q4 2021 | $89.2M | +296% |
CDRO has the edge over NKE in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | 2.7% | +18 points |
| Q2 2024 | 1.6% | +17 points |
| Q1 2024 | 1.6% | +50 points |
| Q4 2023 | -4% | +85 points |
| Q2 2023 | -15% | +5.7 points |
| Q1 2023 | -15% | +5.7 points |
| Q4 2022 | -48% | -38 points |
| Q4 2021 | -89% | -62 points |
CDRO's operating margin was 2.7% last quarter, up 18 points from the same quarter a year ago, near the top of its range since 2020.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CDRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | -$243.8K | -$239.7K |
| Q1 2024 | -$243.8K | -$239.7K |
CDRO's free cash flow has turned negative after years in the green: −$495,966 over the past year.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CDRO Net Leverage
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CDRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.1 | Neutral |
| Stochastic | 15.8 | Oversold |
CDRO's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CDRO PE vs Consumer Cyclical Sector
| Metric | CDRO | Sector median | Relative |
|---|---|---|---|
| PE | 85x | 18x | 372% above |
| PE % | 65 | 51 | 14 pts above |
CDRO is trading at 85x earnings, a 372% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over CDRO on valuation relative to its sector.
CDRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.14 | 6.6% below |
| 20 week MA | $9.18 | 7% below |
| 50 week MA | $8.78 | 2.7% below |
| 100 week MA | $8.07 | 5.8% above |
| 200 week MA | $6.57 | 30% above |
CDRO has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CDRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.1 | $6.25 | -38% |
| 2022 | $6.25 | $2.53 | -60% |
| 2023 | $2.53 | $2.94 | +16% |
| 2024 | $2.94 | $6.77 | +130% |
| 2025 | $6.77 | $8.09 | +19% |
| 2026 YTD | $8.09 | $8.54 | +5.6% |
CDRO has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.